Cite
HARVARD Citation
Gibbs, P. et al. (n.d.). 2160 GIV as a novel marker of recurrence risk in MMR proficient stage II colon cancer. European journal of cancer. pp. S387-. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Gibbs, P. et al. (n.d.). 2160 GIV as a novel marker of recurrence risk in MMR proficient stage II colon cancer. European journal of cancer. pp. S387-. [Online].